Shares of biopharmaceutical company Clovis Oncology were soaring on Wednesday after the company said the supplemental new drug application (sNDA) for its prostate cancer treatment Rubraca has been granted priority review status by the Food and Drug Administration. Rucaparib is an oral, small molecule inhibitor of PARP1, PARP2 and PARP3 being developed in multiple tumor … Continue reading “Clovis Oncology Shares Soar on Positive FDA News”
Author: Sophia Vida
Tesla Sales Employees are Petitioning to Get a Higher Base Pay
It was last year that electric vehicle maker Tesla had commission cuts for sales employees…
Netflix Dominates With Oscar Nominations
Streaming giant Netflix has scored the most Oscar nominations this year with 24 nods. This…
Tesla’s Stock Closes At a New All-Time High
Shares of Tesla have been on a rocket in recent weeks. It was not too…
Visa Just Announced a Huge Acquisition
According to a Wall Street Journal report, Visa will acquire Silicon Valley fintech company Plaid,…
Toyota Issues a Recall for Almost 700,000 Vehicles in the U.S.
Japanese automaker Toyota has issued a recall on almost 700,000 vehicles in the U.S. over…
Microsoft to Stop Supporting Computers that Run Windows 7
On Tuesday, Microsoft will stop supporting millions of computers that are still running Windows 7.…
Gwyneth Paltrow Has No Plans to Sell Her Products on Amazon
While Amazon's marketplace has thousands upon thousands of items, Gwyneth Paltrow's Goop products aren't any…
Elon Musk May Soon Be A Father With Girlfriend Grimes
There has been speculation that Tesla CEO and Canadian singer/songwriter Grimes are expecting a child…
HP Rejects Bid Again From Xerox Holdings
This week HP Inc. again rejected a $22 a share unsolicited takeover bid from Xerox…
Facebook’s Zuckeberg Says Breakthrough in Tech Glasses Will Arrive This Decade
Facebook CEO Mark Zuckerberg has projected that there will be a “breakthrough” in augmented reality…
Verizon Eliminates Annual Contracts for TV and Internet
Verizon recently announced that the company is dropping traditional cable bundles that are often bound…
Jim Cramer Calls Kohl’s ‘Road Kill’
According to CNBC's Jim Cramer, Kohl's "is just roadkill." The Mad Money host said, "I’m…
Panera Bread Says It Plans to Offer More Grains and Plant-based Foods
Panera Bread's CEO Niren Chaudhary announced this week to CNBC that the company would be…
